LISA HARRIS: Open Payments
NPI 1801847975 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,067 in 69 payments from 16 companies in 2025. Trend: 2023 $1,428 · 2024 $1,256 · 2025 $1,067
Food & beverage: $1,067
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $207 |
| Lilly USA, LLC | 12 | $169 |
| ABBVIE INC. | 12 | $151 |
| PFIZER INC. | 11 | $138 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $78 |
| Vanda Pharmaceuticals Inc. | 3 | $71 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $52 |
| Abbott Laboratories | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Medtronic, Inc. | 1 | $27 |
Products named: Wegovy, MOUNJARO, QULIPTA, CAPLYTA, FANAPT, PREVNAR 20, XIFAXAN, FREESTYLE LIBRE 3.
Industry payments across KS — which companies pay providers there.
